The DOI matches its Crossref record; 865 of the 865 references it cites were found in a registry or an index.
Strategies to Address Low Drug Solubility in Discovery and Development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 865
Konno, H., & Taylor, L. S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20697 · Cited by 384
Watching Fat Digestion: The formation of visible product phases by pancreatic lipase is described.
Patton, J. S., & Carey, M. C. (1979) · Science · doi:10.1126/science.432636 · Cited by 384
Danson, S., Ferry, D., Alakhov, V, Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., & Ranson, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601856 · Cited by 382
Guzmán, H. R., Tawa, M., Zhang, Z., Ratanabanangkoon, P., Shaw, P., Gardner, C. R., Chen, H., Moreau, J., Almarsson, Ö., & Remenar, J. F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20906 · Cited by 381
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
Charman, S. A., Charman, W. N., Rogge, M. C., Wilson, T. D., Dutko, F. J., & Pouton, C. W. (1992) · Pharmaceutical Research · doi:10.1023/a:1018987928936 · Cited by 374
Self-citationLipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372
Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems
Rodríguez‐hornedo, N., & Murphy, D. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980490h · Cited by 371
Pralhad, T., & Rajendrakumar, K. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(03)00529-6 · Cited by 361
Varma, M. V. S., & Panchagnula, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.003 · Cited by 361
Micron‐Size Drug Particles: Common and Novel Micronization Techniques
Rasenack, N., & Müller, B. W. (2004) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120027417 · Cited by 357
Design and Evaluation of Cyclodextrin-Based Drug Formulation
Uekama, K. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.900 · Cited by 356
Effect of Hydrophobic Chain Length of Surfactants on Enthalpy−Entropy Compensation of Micellization
Chen, L.-J., Lin, S.-Y., & Huang, C.-C. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp9804345 · Cited by 353
Biosynthesis of triacylglycerols
Lehner, R., & Kuksis, A. (1996) · Progress in Lipid Research · doi:10.1016/0163-7827(96)00005-7 · Cited by 348
Medicinal Applications of Cyclodextrins
Szejtli, J. (1994) · Medicinal Research Reviews · doi:10.1002/med.2610140304 · Cited by 347
McClements, D. J. (2012) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2012.03.002 · Cited by 346
Morris, K. R., Griesser, U. J., Eckhardt, C. J., & Stowell, J. G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00100-4 · Cited by 345
High throughput physicochemical profiling for drug discovery
Kerns, E. H. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1134 · Cited by 343
Characterization of the Time Scales of Molecular Motion in Pharmaceutically Important Glasses
Shamblin, S. L., Tang, X., Chang, L., Hancock, B. C., & Pikal, M. J. (1999) · The Journal of Physical Chemistry B · doi:10.1021/jp983964+ · Cited by 340
Hecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.014 · Cited by 339
Interactions of surfactants with lipid membranes
Heerklotz, H. (2008) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583508004721 · Cited by 339
(1999) · PubMed · Cited by 337
Intestinal lymphatic drug transport: an update
Porter, C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00151-x · Cited by 337
Self-citationZhou, D., Zhang, G. G. Z., Law, D., Grant, D. J. W., & Schmitt, E. A. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10169 · Cited by 336
Lindmark, T., Kimura, Y., & Artursson, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37216-7 · Cited by 333
Self-assembled cyclodextrin aggregates and nanoparticles
Messner, M., Kurkov, S. V., Jansook, P., & Loftsson, Þ. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.11.035 · Cited by 327
Drug-Like Property Concepts in Pharmaceutical Design
Di, L., Kerns, E., & Carter, G. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682479 · Cited by 327
Kabanov, A. V., Batrakova, E. V., & Miller, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00176-x · Cited by 325
Warren, D. B., Benameur, H., Porter, C. J. H., & Pouton, C. W. (2010) · Journal of Drug Targeting · doi:10.3109/1061186x.2010.525652 · Cited by 323
Self-citationKozlov, M. Y., Melik-Nubarov, N. S., Batrakova, E. V., & Kabanov, A. V. (2000) · Macromolecules · doi:10.1021/ma991634x · Cited by 322
Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., & Muranishi, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018968611962 · Cited by 320
Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine
Kostewicz, E. S., Wunderlich, M., Brauns, U., Becker, R., Bock, T., & Dressman, J. B. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022511 · Cited by 318
Modification of supercritical fluid phase behavior using polar cosolvents
Dobbs, J. M., Wong, J. M., Lahiere, R. J., & Johnston, K. P. (1987) · Industrial & Engineering Chemistry Research · doi:10.1021/ie00061a011 · Cited by 317
Schmidt, L. E., & Dalhoff, K. (2002) · Drugs · doi:10.2165/00003495-200262100-00005 · Cited by 316
Encapsulation of retinoids in solid lipid nanoparticles (SLN)
Volkhard Jenning, S. H. G. (2001) · Journal of Microencapsulation · doi:10.1080/02652040010000361 · Cited by 315
(C) Means to enhance penetration
Scott Swenson, E., & Curatolo, W. J. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90015-i · Cited by 314
Salt selection for basic drugs
Gould, P. L. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90055-4 · Cited by 314
Verreck, G., Chun, I., Peeters, J., Rosenblatt, J., & Brewster, M. E. (2003) · Pharmaceutical Research · doi:10.1023/a:1023450006281 · Cited by 311
Doxorubicin in sterically stabilized liposomes
Lasic, D. D. (1996) · Nature · doi:10.1038/380561a0 · Cited by 308
Production and characterization of Hesperetin nanosuspensions for dermal delivery
Mishra, P. R., Shaal, L. A., Müller, R. H., & Keck, C. M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.030 · Cited by 308
Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate
Aguiar, A. J., Krc, J., Kinkel, A. W., & Samyn, J. C. (1967) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600560712 · Cited by 307
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307
Sek, L., Porter, C. J. H., Kaukonen, A. M., & Charman, W. N. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021771896 · Cited by 304
Self-citationPaulekuhn, G. S., Dressman, J. B., & Saal, C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701032y · Cited by 304
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Effects of Cyclodextrins on Drug Delivery Through Biological Membranes
Loftsson, T., Vogensen, S. B., Brewster, M. E., & Konráðsdóttir, F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20992 · Cited by 302
Larsen, C., Østergaard, J., Larsen, S. W., Jensen, H., Jacobsen, S., Lindegaard, C., & Andersen, P. H. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21346 · Cited by 301
Surfactants and Polymers in Drug Delivery
(2002) · CRC Press eBooks · doi:10.1201/9780824743758 · Cited by 299
Curatolo, W., Nightingale, J. A., & Herbig, S. M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9852-z · Cited by 298
Müllertz, A., Ogbonna, A., Ren, S., & Rades, T. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01107.x · Cited by 295
Depot Antipsychotic Drugs: Place in Therapy
Davis, J. M., Metalon, L., Watanabe, M. D., & Blake, L. (1994) · Drugs · doi:10.2165/00003495-199447050-00004 · Cited by 295
Kovarik, J. M., Mueller, E. A., Kutz, K., Van Bree, J. B., & Tetzloff, W. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830336 · Cited by 294
Role of Formulation Vehicles in Taxane Pharmacology
van Zuylen, L., Verweij, J., & Sparreboom, A. (2001) · Investigational New Drugs · doi:10.1023/a:1010618632738 · Cited by 293
Caliph, S. M., Charman, W. N., & Porter, C. J. H. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<1073::aid-jps12>3.0.co;2-v · Cited by 292
Self-citationThe Activity Coefficient of Benzene in Aqueous Salt Solutions
McDevit, W. F., & Long, F. A. (1952) · Journal of the American Chemical Society · doi:10.1021/ja01127a048 · Cited by 291
Effect of additives on the micellization of PEO/PPO/PEO block copolymer F127 in aqueous solution
Desai, P. R., Jain, N. J., Sharma, R. K., & Bahadur, P. (2001) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(00)00493-3 · Cited by 289
Staggers, J. E., Hernell, O., Stafford, R. J., & Carey, M. C. (1990) · Biochemistry · doi:10.1021/bi00460a011 · Cited by 289
Pharmaceutical profiling in drug discovery
Kerns, E. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02649-7 · Cited by 288
Loftsson, T., & Brewster, M. E. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01279.x · Cited by 286
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
Hu, L., Tang, X., & Cui, F. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044959 · Cited by 281
Vogt, M., Kunath, K., & Dressman, J. B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.05.010 · Cited by 280
Intestinal lymphatic transport for drug delivery
Yáñez, J. A., Wang, S. W. J., Knemeyer, I. W., Wirth, M. A., & Alton, K. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.019 · Cited by 278
The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)
Pazdur, R., Kudelka, A. P., Kavanagh, J. J., Cohen, P. R., & Raber, M. N. (1993) · Cancer Treatment Reviews · doi:10.1016/0305-7372(93)90010-o · Cited by 278
Drug stability : principles and practices
Carstensen, J. T. (1995) · Medical Entomology and Zoology · Cited by 277
Cyclodextrin-adamantanecarboxylate inclusion complexes: studies of the variation in cavity size
Cromwell, W. C., Bystrom, K., & Eftink, M. R. (1985) · The Journal of Physical Chemistry · doi:10.1021/j100248a029 · Cited by 277
Self‐Association and Cyclodextrin Solubilization of Drugs
Loftsson, T., Magnúsdóttir, A., Másson, M., & Sigurjónsdóttir, J. F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10226 · Cited by 277
Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Tetzloff, W., Grevel, J., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018923912135 · Cited by 275
Wu, Y., Loper, A., Landis, E., Hettrick, L., Novak, L., Lynn, K., Chen, C., Thompson, K., Higgins, R., Batra, U., et al. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.001 · Cited by 275
Wiernik, P. H., Schwartz, E. L., Einzig, A., Strauman, J. J., Lipton, R. B., & Dutcher, J. P. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1232 · Cited by 275
Liposomal and Lipid Formulations of Amphotericin B: Clinical Pharmacokinetics
Janknegt, R., de Marie, S., Bakker-Woudenberg, I. A. J. M., & Crommelin, D. J. A. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223040-00004 · Cited by 274
Williams, H. D., Sassene, P., Kleberg, K., Bakala-N'Goma, J.-C., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., Jule, E., et al. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23205 · Cited by 274
Self-citationPeeters, J., Neeskens, P., Tollenaere, J. P., Van Remoortere, P., & Brewster, M. E. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10126 · Cited by 272
Self-Assembly of β-Cyclodextrin in Water. Part 1: Cryo-TEM and Dynamic and Static Light Scattering
Bonini, M., Rossi, S., Karlsson, G., Almgren, M., Lo Nostro, P., & Baglioni, P. (2006) · Langmuir · doi:10.1021/la052878f · Cited by 272
Speybroeck, M. V., Barillaro, V., Thi, T. D., Mellaerts, R., Martens, J., Humbeeck, J. V., Vermant, J., Annaert, P., Den Mooter, G. V., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21638 · Cited by 270
Wasan, K. M., Brocks, D. R., Lee, S. D., Sachs-Barrable, K., & Thornton, S. J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2353 · Cited by 269
Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs
Rasenack, N., & Müller, B. W. (2002) · Pharmaceutical Research · doi:10.1023/a:1021410028371 · Cited by 262
The glass transition temperature versus the fictive temperature
Badrinarayanan, P., Zheng, W., Li, Q., & Simon, S. L. (2007) · Journal of Non-Crystalline Solids · doi:10.1016/j.jnoncrysol.2007.04.025 · Cited by 258
Lipid digestion and absorption in early life: an update
Lindquist, S., & Hernell, O. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328337bbf0 · Cited by 257
Unmasking the dynamic interplay between efflux transporters and metabolic enzymes
Benet, L. Z., Cummins, C. L., & Wu, C. Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2002.12.002 · Cited by 256
Ngai, K. L., Lunkenheimer, P., León, C., Schneider, U., Brand, R., & Loidl, A. (2001) · The Journal of Chemical Physics · doi:10.1063/1.1381054 · Cited by 254
Constantinides, P. P., Scalart, J.-P., Lancaster, C., Marcello, J., Marks, G., Ellens, H., & Smith, P. L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018927402875 · Cited by 253
Wong, J., Brugger, A., Khare, A., Chaubal, M., Papadopoulos, P., Rabinow, B., Kipp, J., & Ning, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.008 · Cited by 251
Nucleation and crystal growth in supersaturated solutions of a model drug
Lindfors, L., Forssén, S., Westergren, J., & Olsson, U. (2008) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2008.05.034 · Cited by 251
Oh, K. T., Bronich, T. K., & Kabanov, A. V. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.10.018 · Cited by 250
Verreck, G., Six, K., Van den Mooter, G., Baert, L., Peeters, J., & Brewster, M. E. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00591-4 · Cited by 250
Lingual Lipase and Its Role in the Digestion of Dietary Lipid
Hamosh, M., & Scow, R. O. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107177 · Cited by 248
Intestinal lipid absorption and transport
Phan, C. (2001) · Frontiers in Bioscience · doi:10.2741/phan · Cited by 247
(2007) · Desk Reference of Clinical Pharmacology, Second Edition · doi:10.1201/9781420047448.ch5 · Cited by 247
Six, K., Verreck, G., Peeters, J., Brewster, M., & Mooter, G. V. D. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10522 · Cited by 246
Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities
Bastin, R. J., Bowker, M. J., & Slater, B. J. (2000) · Organic Process Research & Development · doi:10.1021/op000018u · Cited by 245
Mellaerts, R., Mols, R., Jammaer, J. A. G., Aerts, C. A., Annaert, P., Van Humbeeck, J., Van den Mooter, G., Augustijns, P., & Martens, J. A. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.11.006 · Cited by 244
Türk, M., Hils, P., Helfgen, B., Schaber, K., Martin, H.-J., & Wahl, M. A. (2002) · The Journal of Supercritical Fluids · doi:10.1016/s0896-8446(01)00109-7 · Cited by 244
Casley-Smith, J. R. (1962) · The Journal of Cell Biology · doi:10.1083/jcb.15.2.259 · Cited by 244
Banerjee, R., Bhatt, P. M., Ravindra, N. V., & Desiraju, G. R. (2005) · Crystal Growth & Design · doi:10.1021/cg050125l · Cited by 243
Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.
Kemper, E. M., van Zandbergen, A. E., Cleypool, C. G. J., Mos, H. A., Boogerd, W. J., Beijnen, J. H., & van Tellingen, O. (2003) · PubMed · Cited by 243
Surfactants in nonpolar solvents
Eicke, H. (2006) · Springer eBooks · doi:10.1007/bfb0048489 · Cited by 242
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo
Linn, M., Collnot, E.-M., Djuric, D., Hempel, K., Fabian, E., Kolter, K., & Lehr, C.-M. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.11.025 · Cited by 242
Porter, C. J. H., Kaukonen, A. M., Boyd, B. J., Edwards, G. A., & Charman, W. N. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036914.22132.cc · Cited by 242
Self-citationZhang, H., Yao, M., Morrison, R. A., & Chong, S. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02976689 · Cited by 242
Cole, E. T., Cadé, D., & Benameur, H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.009 · Cited by 241
Estimating drug solubility in the gastrointestinal tract
Dressman, J. B., Vertzoni, M., Goumas, K., & Reppas, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.009 · Cited by 237
Hugger, E. D., Novak, B. L., Burton, P. S., Audus, K. L., & Borchardt, R. T. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10176 · Cited by 237
Lakshman, J. P., Cao, Y., Kowalski, J., & Serajuddin, A. T. M. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8001073 · Cited by 236
Physicochemical Properties of Pharmaceutical Co-Crystals: A Case Study of Ten AMG 517 Co-Crystals
Stanton, M. K., & Bak, A. (2008) · Crystal Growth & Design · doi:10.1021/cg800173d · Cited by 236
Injectable Lipid Emulsions—Advancements, Opportunities and Challenges
Hippalgaonkar, K., Majumdar, S., & Kansara, V. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9526-5 · Cited by 236
Application of Mesoporous Silicon Dioxide and Silicate in Oral Amorphous Drug Delivery Systems
Qian, K. K., & Bogner, R. H. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22779 · Cited by 235
SCHWARZ, C. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289185 · Cited by 235
Lo, Y.-L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00163-9 · Cited by 233
Reversal of multidrug resistance by surfactants
Woodcock, D., Linsenmeyer, M., Chojnowski, G., Kriegler, A., Nink, V, Webster, L., & Sawyer, W. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.217 · Cited by 233
Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide
Jacobs, C., Kayser, O., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00412-3 · Cited by 232
Sha, X., Yan, G., Wu, Y., Li, J., & Fang, X. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.001 · Cited by 231
Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials
Mellaerts, R., Aerts, C. A., Humbeeck, J. V., Augustijns, P., den Mooter, G. V., & Martens, J. A. (2007) · Chemical Communications · doi:10.1039/b616746b · Cited by 231
Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J. M., Pugh, S., Polin, L., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016051316815 · Cited by 230
Advances in lipid nanodispersions for parenteral drug delivery and targeting
Constantinides, P. P., Chaubal, M. V., & Shorr, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.013 · Cited by 230
Dahan, A., & Hoffman, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.017 · Cited by 230
Fernandes, C. M., Teresa Vieira, M., & B. Veiga, F. J. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00208-1 · Cited by 228
Local Mobility in Amorphous Pharmaceuticals—Characterization and Implications on Stability
Bhattacharya, S., & Suryanarayanan, R. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21728 · Cited by 228
Peters, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.77 · Cited by 228
The drug efflux–metabolism alliance: biochemical aspects
Benet, L. Z., & Cummins, C. L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00178-8 · Cited by 226
Developing early formulations: Practice and perspective
Li, P., & Zhao, L. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.049 · Cited by 225
Spray Drying Technique: II. Current Applications in Pharmaceutical Technology
Sollohub, K., & Cal, K. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21963 · Cited by 225
Baert, L., van ‘t Klooster, G., Dries, W., François, M., Wouters, A., Basstanie, E., Iterbeke, K., Stappers, F., Stevens, P., Schueller, L., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.03.006 · Cited by 224
Dahan, A., Miller, J. M., Hoffman, A., Amidon, G. E., & Amidon, G. L. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22033 · Cited by 224
Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique
Jung, J.-Y., Yoo, S. D., Lee, S.-H., Kim, K.-H., Yoon, D.-S., & Lee, K.-H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00191-x · Cited by 221
Gao, P., & Morozowich, W. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.1.97 · Cited by 221
Influence of lipolysis on drug absorption from the gastro-intestinal tract
MacGregor, K. J., Embleton, J. K., Lacy, J. E., Perry, E. A., Solomon, L. J., Seager, H., & Pouton, C. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00489-9 · Cited by 221
Self-citationStability and Solubility of Celecoxib-PVP Amorphous Dispersions: A Molecular Perspective
Gupta, P., Kakumanu, V. K., & Bansal, A. K. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045226.42859.b8 · Cited by 219
Gao, F., Zhang, Z., Bu, H., Huang, Y., Gao, Z., Shen, J., Zhao, C., & Li, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.013 · Cited by 219
Bak, A., Gore, A., Yanez, E., Stanton, M., Tufekcic, S., Syed, R., Akrami, A., Rose, M., Surapaneni, S., Bostick, T., et al. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21280 · Cited by 218
Efficient Co-crystal Screening Using Solution-Mediated Phase Transformation
Zhang, G. G. Z., Henry, R. F., Borchardt, T. B., & Lou, X. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20949 · Cited by 217
NEWA, M., BHANDARI, K., LI, D., KWON, T., KIM, J., YOO, B., WOO, J., LYOO, W., YONG, C., & CHOI, H. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.031 · Cited by 217
Porter, C. J. H., Kaukonen, A. M., Taillardat-Bertschinger, A., Boyd, B. J., O'Connor, J. M., Edwards, G. A., & Charman, W. N. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20039 · Cited by 216
Self-citationWon, D.-H., Kim, M.-S., Lee, S., Park, J.-S., & Hwang, S.-J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.017 · Cited by 216
Takeuchi, H., Nagira, S., Yamamoto, H., & Kawashimà, Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.019 · Cited by 216
Sjöström, B., & Bergenståhl, B. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90303-j · Cited by 215
Thomas, N., Holm, R., Müllertz, A., & Rades, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.027 · Cited by 215
Anderberg, E. K., Nyström, C., & Artursson, P. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810908 · Cited by 214
Dissolution Kinetics of Carboxylic Acids I: Effect of pH Under Unbuffered Conditions
Mooney, K. G., Mintun, M. A., Himmelstein, K. J., & Stella, V. J. (1981) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600700103 · Cited by 212
Harivardhan Reddy, L., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. S. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.028 · Cited by 212
Yi, T., Wan, J., Xu, H., & Yang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.001 · Cited by 209
Nicolaides, E., Symillides, M., Dressman, J. B., & Reppas, C. (2001) · Pharmaceutical Research · doi:10.1023/a:1011071401306 · Cited by 208
Gao, P., Guyton, M. E., Huang, T., Bauer, J. M., Stefanski, K. J., & Lu, Q. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120028718 · Cited by 208
Lipid nanoparticles for the delivery of poorly water-soluble drugs
Bunjes, H. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01024.x · Cited by 207
Constantinides, P. P., & Wasan, K. M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20780 · Cited by 207
Batrakova, E. V., Li, S., Miller, D. W., & Kabanov, A. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018990706838 · Cited by 206
Kaukonen, A. M., Boyd, B. J., Porter, C. J. H., & Charman, W. N. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016282.77887.1f · Cited by 206
Self-citationThe Biogenesis of Chylomicrons
Mansbach, C. M., & Siddiqi, S. A. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135801 · Cited by 206
Cyclodextrin nephrosis in the rat.
Frank, D. W., Gray, J. E., & Weaver, R. N. (1976) · PubMed · Cited by 204
Preparation of a chemically stable quercetin formulation using nanosuspension technology
Gao, L., Liu, G., Wang, X., Liu, F., Xu, Y., & Ma, J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.009 · Cited by 204
Van Speybroeck, M., Mellaerts, R., Mols, R., Thi, T. D., Martens, J. A., Van Humbeeck, J., Annaert, P., Van den Mooter, G., & Augustijns, P. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.09.002 · Cited by 204
Nanoparticles for Drug Delivery
(2021) · Gels Horizons: From Science to Smart Materials · doi:10.1007/978-981-16-2119-2 · Cited by 203
HANAFY, A., SPAHNLANGGUTH, H., VERGNAULT, G., GRENIER, P., TUBICGROZDANIS, M., LENHARDT, T., & LANGGUTH, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.005 · Cited by 203
Surfactants in membrane solubilisation
Jones, M. N. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00345-7 · Cited by 203
Murdande, S. B., Pikal, M. J., Shanker, R. M., & Bogner, R. H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0269-5 · Cited by 201
Self-citationPharmaceutical Emulsions and Suspensions
(2000) · CRC Press eBooks · doi:10.1201/9780429344688 · Cited by 200
Determination of baseline human nasal pH and the effect of intranasally administered buffers
Washington, N., Steele, R. J. C., Jackson, S. J., Bush, D., Mason, J., Gill, D. A., Pitt, K., & Rawlins, D. A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00442-1 · Cited by 200
Kossena, G. A., Boyd, B. J., Porter, C. J. H., & Charman, W. N. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10329 · Cited by 199
Self-citationAccuracy of calculated pH-dependent aqueous drug solubility
Bergström, C. A. S., Luthman, K., & Artursson, P. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.04.006 · Cited by 197
Nonclinical Vehicle Use in Studies by Multiple Routes in Multiple Species
Gad, S. C., Cassidy, C. D., Aubert, N., Spainhour, B., & Robbe, H. (2006) · International Journal of Toxicology · doi:10.1080/10915810600961531 · Cited by 197
Rumondor, A. C. F., Stanford, L. A., & Taylor, L. S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9974-3 · Cited by 195
Shiraki, K., Takata, N., Takano, R., Hayashi, Y., & Terada, K. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9676-2 · Cited by 195
Dahan, A., & Hoffman, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9054-x · Cited by 195
Johnson, B. M., Charman, W. N., & Porter, C. J. H. (2002) · AAPS PharmSci · doi:10.1208/ps040440 · Cited by 193
Self-citationChristensen, J. Ø., Schultz, K., Mollgaard, B., Kristensen, H. G., & Mullertz, A. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.08.003 · Cited by 186
Formulation of amphotericin B as nanosuspension for oral administration
Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 186
van ′t Klooster, G., Hoeben, E., Borghys, H., Looszova, A., Bouche, M.-P., van Velsen, F., & Baert, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01529-09 · Cited by 186
Bogman, K., Erne-Brand, F., Alsenz, J., & Drewe, J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10395 · Cited by 184
Crounse, R. G. (1961) · Journal of Investigative Dermatology · doi:10.1038/jid.1961.154 · Cited by 184
Van Eerdenbrugh, B., Baird, J. A., & Taylor, L. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22214 · Cited by 182
Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective
Chen, M.-L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.010 · Cited by 182
Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state
Mura, P. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00035-0 · Cited by 182
Pajula, K., Taskinen, M., Lehto, V.-P., Ketolainen, J., & Korhonen, O. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900304p · Cited by 179
Dahan, A., & Hoffman, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.12.006 · Cited by 179
Prediction of the Thermal Phase Diagram of Amorphous Solid Dispersions by Flory–Huggins Theory
Zhao, Y., Inbar, P., Chokshi, H. P., Malick, A. W., & Choi, D. S. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22541 · Cited by 178
de Waard, H., Hinrichs, W. L. J., & Frijlink, H. W. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.002 · Cited by 175
Cuiné, J. F., McEvoy, C. L., Charman, W. N., Pouton, C. W., Edwards, G. A., Benameur, H., & Porter, C. J. H. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21246 · Cited by 175
Self-citationLi, S., Wong, S., Sethia, S., Almoazen, H., Joshi, Y. M., & Serajuddin, A. T. M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2504-z · Cited by 174
Malcolmson, C., Satra, C., Kantaria, S., Sidhu, A., & Jayne Lawrence, M. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9700863 · Cited by 174
Altered Pharmacokinetics of Vinblastine in Mdr1a P-glycoprotein-Deficient Mice
van Asperen, J., Schinkel, A. H., Beijnen, J. H., Nooijen, W. J., Borst, P., & van Tellingen, O. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.14.994 · Cited by 174
Effects of ionic protein denaturants on micelle formation by nonionic detergents
Ray, A., & Némethy, G. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00754a014 · Cited by 172
Bioavailability of indomethacin-saccharin cocrystals
Jung, M.-S., Kim, J.-S., Kim, M.-S., Alhalaweh, A., Cho, W., Hwang, S.-J., & Velaga, S. P. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01189.x · Cited by 171
Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution
Chen, X., Young, T. J., Sarkari, M., Williams, R. O., & Johnston, K. P. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00147-3 · Cited by 171
Mohsin, K., Long, M. A., & Pouton, C. W. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21659 · Cited by 171
Self-citationRegev, R., Assaraf, & Eytan, G. D. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00037.x · Cited by 171
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Grevel, J., Lücker, P. W., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018922517162 · Cited by 170
Andronis, V., & Zografi, G. (1998) · Pharmaceutical Research · doi:10.1023/a:1011960112116 · Cited by 170
Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion
Six, K., Daems, T., de Hoon, J., Van Hecken, A., Depre, M., Bouche, M.-P., Prinsen, P., Verreck, G., Peeters, J., Brewster, M. E., et al. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.10.005 · Cited by 170
Dissolution Behavior of Polymorphs of Chloramphenicol Palmitate and Mefenamic Acid
Aguiar, A. J., & Zelmer, J. E. (1969) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600580817 · Cited by 170
Wilson, F. A., Sallee, V. L., & Dietschy, J. M. (1971) · Science · doi:10.1126/science.174.4013.1031 · Cited by 170
Structure, Solubility, Screening, and Synthesis of Molecular Salts
Black, S. N., Collier, E. A., Davey, R. J., & Roberts, R. J. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20927 · Cited by 170
Mansbach, C. M., & Gorelick, F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00299.2007 · Cited by 170
Schou, M. (1958) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1958.tb00287.x · Cited by 169
Production of micro- and nano-composite particles by supercritical carbon dioxide
Bahrami, M., & Ranjbarian, S. (2007) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2006.05.006 · Cited by 169
van Drooge, D. J., Hinrichs, W. L. J., Visser, M. R., & Frijlink, H. W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.007 · Cited by 169
Woodcock, D. M., Jefferson, S., Linsenmeyer, M. E., Crowther, P. J., Chojnowski, G. M., Williams, B. T., & Bertoncello, I. (1990) · PubMed · Cited by 168
Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders
Lu, A. T. K., Frisella, M. E., & Johnson, K. C. (1993) · Pharmaceutical Research · doi:10.1023/a:1018917729477 · Cited by 166
Gao, P., Akrami, A., Alvarez, F., Hu, J., Li, L., Ma, C., & Surapaneni, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21451 · Cited by 166
Simulated intestinal fluid as transport medium in the Caco-2 cell culture model
Ingels, F., Deferme, S., Destexhe, E., Oth, M., Van den Mooter, G., & Augustijns, P. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00897-3 · Cited by 166
Eldem, T., Speiser, P., & Hincal, A. (1991) · Pharmaceutical Research · doi:10.1023/a:1015874121860 · Cited by 165
Shono, Y., Nishihara, H., Matsuda, Y., Furukawa, S., Okada, N., Fujita, T., & Yamamoto, A. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20017 · Cited by 165
Cited by
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Baghel, S., Cathcart, H., & O'Reilly, N. J. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.008 · Cited by 970
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Metadata
- Authors
- Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 65
- Issue
- 1
- Pages
- 315-499
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2133061394
- Cited by
- 1,570
- References
- 865
- FWCI
- 56.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.